2015年
- December 11, 2015
- Release of KIPRES OD Tablets 10mg, a treatment for bronchial asthma and allergic rhinitis
- December 11, 2015
- NHI Drug Price Listing of PENTASA Granules 94%, a treatment for Ulcerative Colitis and Crohn's Disease
- November 5, 2015
- KYORIN Pharmaceutical and PeptiDream Reach Agreement for Peptide Discovery Collaboration
- November 5, 2015
- Consolidated Financial Results (For the second Quarter Ended Sep 30,2015)- Supplementary Information
- November 5, 2015
- Summary of Consolidated Financial Results (For the second Quarter Ended Sep 30,2015)［Japanese Standard］
- October 15, 2015
- MSD Submits New Drug Application for Antiallergic Agent, Desloratadine to be Co-marketed with Kyorin
- August 31, 2015
- KYORIN Pharmaceutical and Synmosa Biopharma Corporation Sign License Agreement of Imidafenacin in Taiwan
- August 17, 2015
- Approval received for PENTASA Granules 94%, a treatment for Ulcerative Colitis and Crohn's Disease
- August 17, 2015
- Approval received for KIPRES OD Tablets 10mg, a treatment for bronchial asthma and allergic rhinitis
- July 30, 2015
- Summary of Consolidated Financial Results (For the First Quarter Ended June 30,2015)［Japanese Standard］
- July 30, 2015
- Consolidated Financial Results (For the First Quarter Ended June 30,2015)- Supplementary Information
- May 20, 2015
- Release of Eklira Genuair, a treatment for COPD
- May 13, 2015
- Summary of Consolidated Financial Results (For the fiscal year ended March 31, 2015) [Japanese Standard]
- March 26, 2015
- Genuair, a dry powder inhaler for COPD treatment, selected for iF UNIVERSAL DESIGN award for 2015
- March 26, 2015
- Approval received for Eklira Genuair, a treatment for COPD
- 1